Stay updated with breaking news from Single Pill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: APONTIS PHARMA AG / Key word: Personnel APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO 16.12.2021 / 07:30 The issuer is... | December 16, 2021
14.12.2021 - DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch/Alliance APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rights 14.12.2021 / 07:30 The issuer is solely ... Seite 1
DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance APONTIS PHARMA marks further success in the roll-out of Single Pill therapy 12.07.2021 / 07:30 APONTIS PHARMA marks further success in the roll-out of Single Pill therapy Monheim am Rhein, 12 July 2021. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, continues to achieve success in the roll-out of its own product portfolio. The therapeutic effectiveness of Single Pills was verified in the study "Effect of Single pill combinations on Treatment Real-w...
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 12.07.2021 / 07:30 APONTIS PHARMA marks further success in the roll-out of Single Pill therapy Monheim am Rhein, 12 July 2021. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pills in the German market, continues to achieve success in the roll-out of its own product portfolio. The therapeutic effectiveness of Single Pills was verified in the study "Effect of Single pill combinations on Treatment Real...
DGAP-News: APONTIS PHARMA AG: APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie 12.07.2021 / 07:30 APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie Monheim am Rhein, 12. Juli 2021 . Die APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), ein führendes Pharmaunternehmen für Single Pills im deutschen Markt, macht weitere Fortschritte bei der Verbreitung des eigenen Produktportfolios. Den Therapieerfolg der Single Pills belegt die 2019 durchgefü...